XML 22 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (28,563,283) $ (5,966,287)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 2,192,982 540,196
Common stock and stock option based compensation for employees and board of directors 4,974,519 2,893,297
Acquisition contingent consideration fair value adjustment (696,722) (1,862,229)
Impairment of intangible assets 15,351,842
Issuance of common stock to vendors as compensation 5,238 188,336
Loss on conversion of convertible notes 279,730
Forgiveness of Paycheck Protection Program loan (623,828)
Adjustment to operating lease right-of-use asset and liability (8,330)
Changes in operating assets and liabilities:    
Accounts receivable 132,193 (295,076)
Pre-offering costs 470,136
Deferred costs/contract assets 433,557 (17,900)
Prepaid expenses and other current assets (182,410) (330,496)
Other assets 149,963 (32,000)
Accounts payable (419,716) (132,032)
Accrued liabilities 18,580 (73,475)
Accrued bonuses (138,761) (271,095)
Deferred revenue/contract liabilities (2,412,066) 291,858
Net cash used in operating activities (9,162,414) (4,940,865)
Cash flow from investing activities:    
Purchases of equipment (146,333) (201,998)
Acquisitions, net of cash acquired (2,627,261) (4,615,894)
Payment of contingent consideration for acquisitions (1,000,000)
Sale (purchase) of investments 239,314 (239,314)
Net cash used in investing activities (3,534,280) (5,057,206)
Cash flows from financing activities:    
Proceeds from initial public offering, net 11,821,364
Proceeds from securities purchase agreement, net 13,578,400
Proceeds from exercise of stock options 66,111 1,326,044
Issuance of note receivable (250,000)
Net cash provided by financing activities 66,111 26,475,808
Net change in cash, cash equivalents and restricted cash (12,630,583) 16,477,737
Cash, cash equivalents and restricted cash, beginning of year 18,249,666 1,771,929
Cash, cash equivalents and restricted cash, end of year 5,619,083 18,249,666
Non-cash Investing and Financing activities:    
Common stock issued for acquisitions 2,846,144 3,347,303
Common stock issued for satisfaction of prior year acquisition lability 734,037
Common stock issued for purchase of intangible asset - technology 326,435
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment 318,571
Extinguishment of note receivable for satisfaction of contingent liability 250,000
Contingent acquisition consideration liability recorded at closing 7,325,000 9,169,200
Issuance of common stock for satisfaction of contingent liability 3,059,363
Lease liabilities arising from right-of-use assets 429,329
Forgiveness of Paycheck Protection Program loan 623,828
Issuance of common stock for satisfaction of legacy acquisition liability 1,250,000
Conversion of convertible promissory notes into common stock 1,606,176
Issuance of warrants in connection with initial public offering 522,360
Issuance of warrants in connection with securities purchase agreement $ 8,797,546